Pharmaceutical Sberbank, Russia’s largest state-owned bank, is expanding into the domestic pharmaceutical market, with the establishment of a new company that will focus on the production of drugs, active ingredients, as well as a vaccine against COVID-19, according to recent statements by representatives of the bank and some Russian media, reports The Pharma Letter’s local correspondent. 27 May 2020